145 related articles for article (PubMed ID: 28827305)
1. Could antiseptic mouthwash inhibit pharyngeal
Chow EPF; Fairley CK
Sex Transm Infect; 2017 Sep; 93(6):403. PubMed ID: 28827305
[No Abstract] [Full Text] [Related]
2. Antiseptic mouthwash against pharyngeal
Chow EP; Howden BP; Walker S; Lee D; Bradshaw CS; Chen MY; Snow A; Cook S; Fehler G; Fairley CK
Sex Transm Infect; 2017 Mar; 93(2):88-93. PubMed ID: 27998950
[TBL] [Abstract][Full Text] [Related]
3. A multicentre double-blind randomised controlled trial evaluating the efficacy of daily use of antibacterial mouthwash against oropharyngeal gonorrhoea among men who have sex with men: the OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study protocol.
Chow EPF; Walker S; Hocking JS; Bradshaw CS; Chen MY; Tabrizi SN; Howden BP; Law MG; Maddaford K; Read TRH; Lewis DA; Whiley DM; Zhang L; Grulich AE; Kaldor JM; Cornelisse VJ; Phillips S; Donovan B; McNulty AM; Templeton DJ; Roth N; Moore R; Fairley CK
BMC Infect Dis; 2017 Jun; 17(1):456. PubMed ID: 28659133
[TBL] [Abstract][Full Text] [Related]
4. Self-Reported Use of Mouthwash and Pharyngeal Gonorrhoea Detection by Nucleic Acid Amplification Test.
Chow EPF; Walker S; Read TRH; Chen MY; Bradshaw CS; Fairley CK
Sex Transm Dis; 2017 Oct; 44(10):593-595. PubMed ID: 28876323
[TBL] [Abstract][Full Text] [Related]
5. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
Harry TC
Int J STD AIDS; 2005 Jul; 16(7):520. PubMed ID: 16004640
[No Abstract] [Full Text] [Related]
6. Inhibitory Activity of Antibacterial Mouthwashes and Antiseptic Substances against Neisseria gonorrhoeae.
Williams E; Zhang B; Chow EPF; Chea S; Phillips TR; Maddaford K; Krysiak M; Nong Y; Stefanatos H; Pasricha S; Fairley CK; Wiliamson DA
Antimicrob Agents Chemother; 2022 Jun; 66(6):e0004222. PubMed ID: 35579459
[TBL] [Abstract][Full Text] [Related]
7. Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men: a 13-year retrospective cohort study.
Ota KV; Fisman DN; Tamari IE; Smieja M; Ng LK; Jones KE; Diprima A; Richardson SE
Clin Infect Dis; 2009 May; 48(9):1237-43. PubMed ID: 19323630
[TBL] [Abstract][Full Text] [Related]
8. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.
Y Chen M; Stevens K; Tideman R; Zaia A; Tomita T; Fairley CK; Lahra M; Whiley D; Hogg G
J Antimicrob Chemother; 2013 Jun; 68(6):1445-7. PubMed ID: 23390207
[No Abstract] [Full Text] [Related]
9. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.
Hustig A; Bell C; Waddell R
Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709
[TBL] [Abstract][Full Text] [Related]
10. Pharyngeal Gonorrhea in female sex workers: Response to a single 2-g dose of azithromycin.
Dan M; Poch F; Amitai Z; Gefen D; Shohat T
Sex Transm Dis; 2006 Aug; 33(8):512-5. PubMed ID: 16572040
[TBL] [Abstract][Full Text] [Related]
11. Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre trial.
Chow EPF; Williamson DA; Hocking JS; Law MG; Maddaford K; Bradshaw CS; McNulty A; Templeton DJ; Moore R; Murray GL; Danielewski JA; Wigan R; Chen MY; Guy RJ; Zhang L; Donovan B; Grulich AE; Kaldor JM; Whiley DM; Cornelisse VJ; Howden BP; Lewis DA; Read TRH; Fairley CK
Lancet Infect Dis; 2021 May; 21(5):647-656. PubMed ID: 33676595
[TBL] [Abstract][Full Text] [Related]
12. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
[TBL] [Abstract][Full Text] [Related]
13. Detection of Neisseria gonorrhoeae in the pharynx and saliva: implications for gonorrhoea transmission.
Chow EP; Lee D; Tabrizi SN; Phillips S; Snow A; Cook S; Howden BP; Petalotis I; Bradshaw CS; Chen MY; Fairley CK
Sex Transm Infect; 2016 Aug; 92(5):347-9. PubMed ID: 26622046
[TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.
Unemo M; Golparian D; Hestner A
Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645
[TBL] [Abstract][Full Text] [Related]
15. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.
Golparian D; Ohlsson A; Janson H; Lidbrink P; Richtner T; Ekelund O; Fredlund H; Unemo M
Euro Surveill; 2014 Jul; 19(30):. PubMed ID: 25108533
[TBL] [Abstract][Full Text] [Related]
16. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods.
Tapsall J; Read P; Carmody C; Bourne C; Ray S; Limnios A; Sloots T; Whiley D
J Med Microbiol; 2009 May; 58(Pt 5):683-687. PubMed ID: 19369534
[TBL] [Abstract][Full Text] [Related]
17. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
Manavi K; Young H; McMillan A
Int J STD AIDS; 2005 Jan; 16(1):68-70. PubMed ID: 15705277
[TBL] [Abstract][Full Text] [Related]
18. Potential effect of antiseptic mouthwash on the incidence of
Xu X; Chow EPF; Shen M; Zou Z; Wang C; Ong JJ; Fairley CK; Zhang L
BMJ Open; 2021 Oct; 11(10):e052823. PubMed ID: 34620667
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of pharyngeal infection by Neisseria gonorrhoeae among human immunodeficiency virus-positive men who have sex with men in downtown Madrid, 2011.
Jiménez E; Pedrazuela MG; Pérez MM; de Mosteyrín SF; Arrieta JJ; Guerrero ML
Int J STD AIDS; 2013 Nov; 24(11):875-8. PubMed ID: 23970602
[TBL] [Abstract][Full Text] [Related]
20. Testing for pharyngeal gonorrhoea in heterosexual men: should we revisit national guidelines?
Dresser M; Hussey J
Int J STD AIDS; 2020 May; 31(6):593-595. PubMed ID: 32295478
[No Abstract] [Full Text] [Related]
[Next] [New Search]
